-
Who we are
Who we are
We are a biotechnology company committed to helping address serious infectious diseases globally through the discovery and development of innovative vaccines to patients around the world.
Build your future with usJoin other passionately curious people who are bringing innovative vaccines to the world
-
What we do
What we do
Novavax creates transformational vaccines that help address some of the world’s most pressing infectious diseases.
COVID-19 UPDATESNovavax has demonstrated its ability to quickly develop viable vaccine candidates for emerging infectious diseases such as COVID-19.
-
Blog
Blog
Novavax is committed to accelerating the development of new and promising vaccines and sharing information based on years of study and experience.
H.C. Wainwright 23rd Annual Global Investment Conference
Monday, September 13, 2021 - Wednesday, September 15, 2021
7:00am - 1:00pm EDT
- Date:Monday, September 13, 2021
- Time:Available on-demand starting at 7:00 a.m. Eastern Time (ET)
- Moderator:Vernon Bernardino
- Novavax participants:Gregory M. Glenn, M.D., President, Research and Development and John J. Trizzino, Executive Vice President, Chief Commercial Officer and Chief Business Officer
- Webcast link:https://journey.ct.events/view/91b61a4f-e373-4b1c-9515-904d57eaa26e
- Panel Date:Wednesday, September 15, 2021
- Time:Available on-demand starting at 12:00 p.m. Eastern Time (ET)
- Panel Title:Best Practices – Planning for the Next Pandemic
- Moderator:Scott Gottlieb, M.D., Physician; Former Commissioner FDA
- Panelist:John J. Trizzino, Executive Vice President, Chief Commercial Officer and Chief Business Officer
- Webcast link:https://journey.ct.events/view/df4da74c-0a2c-499c-a5be-13f994a0d28f
Get notifications for investor updates
Sign up for notifications from Novavax including upcoming events, webcasts, research updates, daily stock closings, SEC filings, and more.
Investor inquiries
Shareholders seeking information can contact investor relations at (240) 268-2022 or email us at [email protected]
Novavax corporate policy prohibits any employees, other than designated spokespersons, from communicating with its investors.
![Graph icon](/sites/default/files/images/Investors-Abstract.png)